[Prospects in neuro-oncology].
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism; D001254:Astrocytoma / Q000378:metabolism; D001812:Blood-Brain Barrier; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004806:Ependymoma / Q000378:metabolism; D005038:Ethylnitrosourea / Q000494:pharmacology; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D051379:Mice; D009374:Neoplasms, Experimental / Q000378:metabolism; D009417:Nerve Tissue / Q000187:drug effects; D009423:Nervous System Neoplasms / Q000188:drug therapy / Q000628:therapy; D009462:Neurology / Q000639:trends*; D009607:Nitrosourea Compounds / Q000627:therapeutic use / Q000633:toxicity; D011379:Prognosis; D011446:Prospective Studies; D051381:Rats; D013234:Stem Cells / Q000187:drug effects
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D005038:Ethylnitrosourea
Prospettive in neurooncologia.